The efficacy and safety of mirogabalin for neuropathic pai
Not Applicable
Recruiting
- Conditions
- neuropathic pain
- Registration Number
- JPRN-UMIN000036855
- Lead Sponsor
- Kajiki Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
can not be self-assessment of pain
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual analogue scale (VAS) is assessed before, and, 1 week, 2 weeks, 1 month, 2 months, 3 months,6 months, 1 year after drug administration
- Secondary Outcome Measures
Name Time Method